Skip to Content

InfuSystem posts ‘strong’ quarter on back of core biz 

InfuSystem posts ‘strong’ quarter on back of core biz 

ROCHESTER HILLS, Mich. – InfuSystem Holdings reported net revenue of $36 million for the second quarter of 2025, a 7% increase compared to the same period last year. 

Of that, Patient Services net revenue was $21.5 million, a 6% increase, reflecting continued strength in its core oncology business. Device Solutions net revenue was $14.5 million, an 8% increase, primarily driven by its direct rental business following the strategic investment made last year to address increased demand for services. 

“We delivered strong second quarter financial results, highlighted by margin expansion, robust cash flow generation and meaningful profitability,” said Carrie Lachance, CEO. “Revenue grew 7% to $36 million and gross margins expanded by 5.7% to 55.2%. For the second quarter, Patient Services revenue increased 6%, reflecting continued strength in our core oncology business. The number of patient treatments continue to grow and ongoing operational efficiencies by our revenue cycle team are driving improved results. We are encouraged by the momentum in our partnership with Smith & Nephew, as our negative pressure pump offering continues to gain traction and demonstrates strong potential for sustained growth. Revenue in Device Solutions increased 8%, primarily driven by our direct rental business following our strategic investment made last year to address increased demand for our services. Direct rental remains a significant contributor to overall profitability. Additionally, we returned approximately $3.5 million to shareholders through stock repurchases, bringing the total return to shareholders in the first half of the year to $6.4 million.” 

2025 full year outlook: 

  • Adjusted EBITDA margin to 20% or higher, a 1.2% increase.  
  • Revenue growth outlook to a range of 6% to 8%, down from the prior range of 8% to 10% to reflect a change in the anticipated ramp-up of Advanced Wound Care and Chemo Mouthpiece.  

Related: InfuSystem, Sanara MedTech to distribute chemo-relief device 

Comments

To comment on this post, please log in to your account or set up an account now.